The Valley Desk

Clinical trial reportPediatric blood & cancerPublished

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Pediatric blood & cancer
Published
Subject terms
Humans; Neoplasms; Rhabdomyosarcoma; Glioma; Neoplasm Recurrence, Local; Phenylurea Compounds; Quinolines; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Follow-Up Studies; Maximum Tolerated Dose; Drug Resistance, Neoplasm
PubMed ID
40313040
PubMed Central ID
PMC12716803
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal